• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长效促性腺激素释放激素类似物D-色氨酸-6-促黄体生成素释放激素与促性腺激素联合用于体外受精和胚胎移植的结果

Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins.

作者信息

Caspi E, Ron-El R, Golan A, Nachum H, Herman A, Soffer Y, Weinraub Z

机构信息

Assaf Harofe Medical Centre, Zerifin, Israel.

出版信息

Fertil Steril. 1989 Jan;51(1):95-9. doi: 10.1016/s0015-0282(16)60435-1.

DOI:10.1016/s0015-0282(16)60435-1
PMID:2521328
Abstract

To avoid cancellation of in vitro fertilization (IVF) because of early luteinization, pituitary suppression by gonadotropin-releasing hormone (GnRH) was carried out in 111 cycles. D-Trp-6-luteinizing hormone-releasing hormone (LH-RH) microcapsules were administered intramuscularly at menstruation and menotropin (hMG) stimulation was started 19 days (mean) later. In 3 cycles (2.7%), only early luteinization occurred. The mean number of oocytes per cycle was 6.7, with a fertilization and cleavage rate of 50 and 95%, respectively. A mean of 3.4 embryos were transferred per cycle. The 111 cycles resulted in 34 clinical pregnancies, 41% per cycle with embryo transfer. The early abortion, multiple pregnancy, and ovarian hyperstimulation rates were 24, 18, and 11%, respectively. It is concluded that D-Trp-6-LH-RH/hMG cycles are associated with a very low occurrence of early luteinization, high number of oocytes and embryos, and a substantial incidence of ovarian hyperstimulation syndrome.

摘要

为避免因过早黄素化而取消体外受精(IVF),对111个周期进行了促性腺激素释放激素(GnRH)垂体抑制。在月经时肌肉注射D-色氨酸-6-促黄体生成素释放激素(LH-RH)微胶囊,19天(平均)后开始用人绝经期促性腺激素(hMG)刺激。在3个周期(2.7%)中,仅发生了过早黄素化。每个周期卵母细胞的平均数为6.7个,受精率和分裂率分别为50%和95%。每个周期平均移植3.4个胚胎。111个周期中有34例临床妊娠,胚胎移植周期的妊娠率为41%。早期流产率、多胎妊娠率和卵巢过度刺激综合征发生率分别为24%、18%和11%。结论是,D-色氨酸-6-LH-RH/hMG周期过早黄素化发生率极低,卵母细胞和胚胎数量多,卵巢过度刺激综合征发生率高。

相似文献

1
Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins.长效促性腺激素释放激素类似物D-色氨酸-6-促黄体生成素释放激素与促性腺激素联合用于体外受精和胚胎移植的结果
Fertil Steril. 1989 Jan;51(1):95-9. doi: 10.1016/s0015-0282(16)60435-1.
2
The use of gonadotropin-releasing hormone analogs for in vitro fertilization: comparison between the standard form and long-acting formulation of D-Trp-6-luteinizing hormone-releasing hormone.促性腺激素释放激素类似物在体外受精中的应用:D-色氨酸-6-促黄体生成素释放激素标准剂型与长效剂型的比较
Fertil Steril. 1989 Jan;51(1):100-4. doi: 10.1016/s0015-0282(16)60436-3.
3
Ovarian hyperstimulation syndrome following D-Trp-6 luteinizing hormone-releasing hormone microcapsules and menotropin for in vitro fertilization.
Fertil Steril. 1988 Dec;50(6):912-6. doi: 10.1016/s0015-0282(16)60371-0.
4
A comparison of clomiphene/menotropins and D-Trp6-LH-RH/menotropins cycles of IVF-ET in the same patients.
Int J Fertil. 1991 May-Jun;36(3):157-61.
5
Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program.体外受精程序中促黄体生成素释放激素激动剂的 flare up 与下调作用之间的比较。 (注:“flare up”在医学领域可能有特定含义,具体需结合上下文准确理解,这里直接保留英文表述是因为不太明确其在该语境下的精准中文术语。)
Fertil Steril. 1988 Sep;50(3):471-5. doi: 10.1016/s0015-0282(16)60135-8.
6
Inclusion of standard and low-dose gonadotropin releasing hormone-analog (short protocol) in controlled ovarian hyperstimulation regimens in normogonadotropic patients aged 40-48 years who are undergoing in vitro fertilization.在年龄40 - 48岁、正在接受体外受精的正常促性腺激素患者的控制性卵巢过度刺激方案中纳入标准剂量和低剂量促性腺激素释放激素类似物(短方案)。
Gynecol Endocrinol. 2004 Nov;19(5):247-52. doi: 10.1080/09513590400019288.
7
[Comparison of a long-acting and short-acting GnRH analog in combination with gonadotropins in in vitro fertilization under various indications].[长效与短效促性腺激素释放激素类似物联合促性腺激素在不同适应证体外受精中的比较]
Geburtshilfe Frauenheilkd. 1989 Feb;49 Suppl 1:85-90. doi: 10.1055/s-2008-1026585.
8
A comparison between a standard and reduced dose of D-Trp-6-luteinizing hormone-releasing hormone administered after pituitary suppression for in-vitro fertilization.垂体抑制后给予标准剂量与减少剂量的D-色氨酸-6-促黄体生成素释放激素用于体外受精的比较。
Hum Reprod. 1994 Oct;9(10):1813-7. doi: 10.1093/oxfordjournals.humrep.a138340.
9
[Combined GnRH analogs/hMG/hCG treatment].
Arch Gynecol Obstet. 1989;245(1-4):931-5. doi: 10.1007/BF02417626.
10
The use of a long-acting gonadotropin-releasing hormone analog(D-Trp-6-LHRH) for improvement of ovarian stimulation in assisted conception programs.使用长效促性腺激素释放激素类似物(D-色氨酸-6-促黄体生成素释放激素)改善辅助生殖计划中的卵巢刺激。
J Formos Med Assoc. 1991 Nov;90(11):1081-5.

引用本文的文献

1
Comparison Between PPOS and GnRHa-Long Protocol in Clinical Outcome with the First IVF/ICSI Cycle: A Randomized Clinical Trial.PPOS与GnRHa长方案在首次体外受精/卵胞浆内单精子注射周期临床结局中的比较:一项随机临床试验
Clin Epidemiol. 2020 Mar 3;12:261-272. doi: 10.2147/CLEP.S226414. eCollection 2020.
2
A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for Fertilization: Long Antagonist Protocol.长效促性腺激素释放激素拮抗剂地加瑞克在控制性卵巢刺激用于受精的黄体期单次使用的概念验证临床试验:长效拮抗剂方案
Front Endocrinol (Lausanne). 2018 Mar 1;9:25. doi: 10.3389/fendo.2018.00025. eCollection 2018.
3
Clinical outcome of one-third-dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation.
在控制性卵巢刺激的长方案中,三分之一剂量长效曲普瑞林的临床结局与半剂量长效曲普瑞林相同。
J Hum Reprod Sci. 2012 Jan;5(1):14-9. doi: 10.4103/0974-1208.97785.
4
GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET).促性腺激素释放激素激动剂与拮抗剂在体外受精-胚胎移植(IVF/ET)中的应用。
Reprod Biol Endocrinol. 2012 Apr 13;10:26. doi: 10.1186/1477-7827-10-26.
5
Oral contraceptive pretreatment does not improve outcome in microdose gonadotrophin-releasing hormone agonist protocol among poor responder intracytoplasmic sperm injection patients.对于卵巢低反应的卵胞浆内单精子注射患者,口服避孕药预处理并不能改善微剂量促性腺激素释放激素激动剂方案的结局。
J Assist Reprod Genet. 2008 Feb-Mar;25(2-3):89-93. doi: 10.1007/s10815-008-9203-8. Epub 2008 Feb 6.
6
Jasmonate, genes, and fragrant signals.茉莉酸、基因与香气信号
Plant Physiol. 1992 Jul;99(3):804-7. doi: 10.1104/pp.99.3.804.
7
Comparison between depot leuprorelin and daily buserelin in IVF.长效亮丙瑞林与每日服用布舍瑞林在体外受精中的比较。
J Assist Reprod Genet. 1995 Jan;12(1):15-9. doi: 10.1007/BF02214123.
8
Ovarian stimulation with gonadotropin-releasing hormone (GnRH) analogue improves the in vitro fertilization (IVF) pregnancy rate with both transvaginal and laparoscopic oocyte recovery.使用促性腺激素释放激素(GnRH)类似物进行卵巢刺激,可提高经阴道和腹腔镜取卵的体外受精(IVF)妊娠率。
J In Vitro Fert Embryo Transf. 1990 Dec;7(6):351-4. doi: 10.1007/BF01130589.
9
Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study.
J In Vitro Fert Embryo Transf. 1990 Dec;7(6):358-62; discussion 363-4. doi: 10.1007/BF01130591.
10
Ovarian suppression with leuprolide acetate: comparison of luteal, follicular, and flare-up administration in controlled ovarian hyperstimulation for oocyte retrieval.
J In Vitro Fert Embryo Transf. 1990 Apr;7(2):94-7. doi: 10.1007/BF01135581.